Eva is a senior scientist at Neurolentech and is mainly involved in cellular reprogramming and management of NLT’s clinical collaborators. She has a strong background in stem cell and neuron culture, as well as organoids. Eva holds a PhD in Neuroscience with a focus on epilepsy genetics.

Melanie is the Lab Manager at Neurolentech, she is part of the team since the beginning and is evolved with the company and a number of different challenges. Melanie is involved in the coordination of clinical data/cell lines from collaborators, administrative tasks, purchase and budget for reagents/consumables and accounting tasks. She organizes and coordinates the laboratory infrastructure and social outings with joy and is responsible for the management of Neurolentech´s cryobank. Melanie holds a Master of Science and is a Clinical Trial Specialist.

Karin is a senior scientist at Neurolentech, working primarily on neuronal differentiation, automation and project management. She is a molecular biologist by training with a specialization in epigenetics. During her PhD, she developed a particular interest in neuroscience by uncovering the mechanism of a genetic disorder characterized by neurodevelopmental defects, including autism.

Federico is a senior research scientist working as main responsible in the characterization of SLC13A5 epilepsy. During his PhD, he studied neurodevelopmental disorders combining induced pluripotent stem cell potential and gene editing technology. At Neurolentech, Federico is developing and characterizing cell culture models based on patient-derived induced pluripotent stem cells to identify new biomarkers for pharmacological treatment in SLC13A5 epilepsy.

Camilla is a senior scientist motivated to fill the gap between current top-notch research and precision medicine available to neurodevelopmental disease patients. With a MSc in developmental biology and a PhD in molecular biology focusing on 3D human brain organoids patterning, Camilla applies her background knowledge to Neurolentech's effort in disease modelling by engineering cell lines with CRISPR technology and generating iNeurons. Her research interests span from microelectrode array recording to bioinformatic analysis of RNA seq data, to characterize Neurolentech's phenotypically diverse collection of patient-derived cells

Maria is a researcher focusing on the cellular reprogramming of somatic cells into brain cells. Maria worked in several institution around the globe, passing through several fields, including cell models, drug targetting for inflamatory pathways and neuron isolation from mouse models. At Neurolentech Maria spends her time caring for patient cells, making sure they are up to standard to be integrated into our cell models. Maria holds a Master of Science from the University of Stockhom.

João is a researcher mainly working in somatic cell reprogramming. With a diverse background encompassing a MSc in Bioengineering with a specialization in Molecular Biotechnology, he has previously employed RNA therapeutics and nanomedicine to develop novel therapies against neurological disorders, becoming proficient with neuronal cell culture and cell models.